Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling

June 1, 2005 |

The American Journal of Pathology. 2005;166:1827-1840. [Link] Gavin J. Gordon,a Graham N. Rockwell,b Roderick V. Jensen,c James G. Rheinwald,d Jonathan N. Glickman,e Joshua P. Aronson,a Brian J. Pottorf,a Matthew D.…

Wnt2 as a new therapeutic target in malignant pleural mesothelioma

May 17, 2005 |

International Journal of Cancer. May 17, 2005. Volume 117, Issue 2, Pages 326 – 332. [Link] Julien Mazieres 1 2, Liang You 1, Biao He 1, Zhidong Xu 1, Sarah…

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients

May 15, 2005 |

Clinical Cancer Research. 2005 May 15;11(10):3814-20. [Link] Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Laboratory of Molecular Biology, Center for Cancer Research, National…

Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress

May 5, 2005 |

The Journal of Biological Chemistry. 2005 Jul 8;280(27):25369-76. Epub 2005 May 5. [Link] Stapelberg M, Gellert N, Swettenham E, Tomasetti M, Witting PK, Procopio A, Neuzil J. Apoptosis Research Group,…

Malignant pericardial mesothelioma. Report of two cases, review of the literature and differential diagnosis

May 1, 2005 |

Tumori. 2005 May-Jun;91(3):276-9. [Link] Papi M, Genestreti G, Tassinari D, Lorenzini P, Serra S, Ricci M, Pasquini E, Nicolini M, Pasini G, Tamburini E, Fattori PP, Ravaioli A. Department of…

Primary malignant peritoneal mesothelioma in an incarcerated groin hernia: report of a case

May 1, 2005 |

Surgery Today. May 2005;35(5):421-4. [Link] Mario Testini1 , Anna Scattone2, Beatrice Di Venere1, Germana Lissidini1, Giuseppe Piccinni1, Silvia Palmisano1 and abriella Serio2 (1) Department of Applications in Surgery of Innovative Technologies,…

P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma

May 1, 2005 |

Clinical Cancer Research. 2005 May 1;11(9):3303-8. [Link] Borczuk AC, Taub RN, Hesdorffer M, Hibshoosh H, Chabot JA, Keohan ML, Alsberry R, Alexis D, Powell CA. Department of Pathology, Columbia University…

The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro

May 1, 2005 |

The Journal of Thorscic Cardiovascular Surgery. 2005 May;129 (5):1010-7. [Link] Cole GW Jr, Alleva AM, Reddy RM, Maxhimer JB, Zuo J, Schrump DS, Nguyen DM. Section of Thoracic Oncology, Surgery…

Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase

May 1, 2005 |

Molecular Cancer Therapeutics. May 1, 2005; 4:835-842. [Link] Maria E. Ramos-Nino1, Giovina Vianale2, Tara Sabo-Attwood1, Luciano Mutti3, Camilo Porta4, Nicholas Heintz1 and Brooke T. Mossman1 1 Department of Pathology, University…

Therapeutic options in malignant pleural mesothelioma

May 1, 2005 |

Pneumologie. 2005 May;59(5):337-48. [Link] Serke M, Loddenkemper R. HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Zentrum fur Pneumologie und Thoraxchirurgie. Abstract Malignant pleural mesothelioma may be treated with surgery, radiotherapy…

Categories